pubmed-article:21128591 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:21128591 | lifeskim:mentions | umls-concept:C0027651 | lld:lifeskim |
pubmed-article:21128591 | lifeskim:mentions | umls-concept:C0002520 | lld:lifeskim |
pubmed-article:21128591 | lifeskim:mentions | umls-concept:C0001128 | lld:lifeskim |
pubmed-article:21128591 | lifeskim:mentions | umls-concept:C0220781 | lld:lifeskim |
pubmed-article:21128591 | lifeskim:mentions | umls-concept:C1883254 | lld:lifeskim |
pubmed-article:21128591 | lifeskim:mentions | umls-concept:C0032743 | lld:lifeskim |
pubmed-article:21128591 | lifeskim:mentions | umls-concept:C0597354 | lld:lifeskim |
pubmed-article:21128591 | lifeskim:mentions | umls-concept:C1533691 | lld:lifeskim |
pubmed-article:21128591 | lifeskim:mentions | umls-concept:C1880022 | lld:lifeskim |
pubmed-article:21128591 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:21128591 | pubmed:dateCreated | 2011-9-15 | lld:pubmed |
pubmed-article:21128591 | pubmed:abstractText | There is a high demand for tumor specific PET tracers in oncology imaging. Besides glucose, certain amino acids also serve as energy sources and anabolic precursors for tumors. Therefore, (18)F-labeled amino acids are interesting probes for tumor specific PET imaging. As glutamine and glutamate play a key role in the adapted intermediary metabolism of tumors, the radiosynthesis of 4-[(18)F]fluoro l-glutamic acid (BAY 85-8050) as a new specific PET tracer was established. Cell-uptake studies revealed specific tumor cell accumulation. | lld:pubmed |
pubmed-article:21128591 | pubmed:language | eng | lld:pubmed |
pubmed-article:21128591 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21128591 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:21128591 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21128591 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21128591 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21128591 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21128591 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:21128591 | pubmed:month | Jan | lld:pubmed |
pubmed-article:21128591 | pubmed:issn | 1520-4804 | lld:pubmed |
pubmed-article:21128591 | pubmed:author | pubmed-author:SchubigerP... | lld:pubmed |
pubmed-article:21128591 | pubmed:author | pubmed-author:FedorovaOlga... | lld:pubmed |
pubmed-article:21128591 | pubmed:author | pubmed-author:DinkelborgLud... | lld:pubmed |
pubmed-article:21128591 | pubmed:author | pubmed-author:GrahamKeithK | lld:pubmed |
pubmed-article:21128591 | pubmed:author | pubmed-author:KoglinNormanN | lld:pubmed |
pubmed-article:21128591 | pubmed:author | pubmed-author:BelokonYuri... | lld:pubmed |
pubmed-article:21128591 | pubmed:author | pubmed-author:FriebeMatthia... | lld:pubmed |
pubmed-article:21128591 | pubmed:author | pubmed-author:LehmannLutzL | lld:pubmed |
pubmed-article:21128591 | pubmed:author | pubmed-author:AmetameySimon... | lld:pubmed |
pubmed-article:21128591 | pubmed:author | pubmed-author:MuLinjingL | lld:pubmed |
pubmed-article:21128591 | pubmed:author | pubmed-author:BerndtMathias... | lld:pubmed |
pubmed-article:21128591 | pubmed:author | pubmed-author:KrasikovaRais... | lld:pubmed |
pubmed-article:21128591 | pubmed:author | pubmed-author:KuznetsovaOlg... | lld:pubmed |
pubmed-article:21128591 | pubmed:author | pubmed-author:MuellerAndreA | lld:pubmed |
pubmed-article:21128591 | pubmed:author | pubmed-author:MaleevViktor... | lld:pubmed |
pubmed-article:21128591 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:21128591 | pubmed:day | 13 | lld:pubmed |
pubmed-article:21128591 | pubmed:volume | 54 | lld:pubmed |
pubmed-article:21128591 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:21128591 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:21128591 | pubmed:pagination | 406-10 | lld:pubmed |
pubmed-article:21128591 | pubmed:meshHeading | pubmed-meshheading:21128591... | lld:pubmed |
pubmed-article:21128591 | pubmed:meshHeading | pubmed-meshheading:21128591... | lld:pubmed |
pubmed-article:21128591 | pubmed:meshHeading | pubmed-meshheading:21128591... | lld:pubmed |
pubmed-article:21128591 | pubmed:meshHeading | pubmed-meshheading:21128591... | lld:pubmed |
pubmed-article:21128591 | pubmed:meshHeading | pubmed-meshheading:21128591... | lld:pubmed |
pubmed-article:21128591 | pubmed:meshHeading | pubmed-meshheading:21128591... | lld:pubmed |
pubmed-article:21128591 | pubmed:meshHeading | pubmed-meshheading:21128591... | lld:pubmed |
pubmed-article:21128591 | pubmed:meshHeading | pubmed-meshheading:21128591... | lld:pubmed |
pubmed-article:21128591 | pubmed:year | 2011 | lld:pubmed |
pubmed-article:21128591 | pubmed:articleTitle | 4-[18F]fluoroglutamic acid (BAY 85-8050), a new amino acid radiotracer for PET imaging of tumors: synthesis and in vitro characterization. | lld:pubmed |
pubmed-article:21128591 | pubmed:affiliation | Institute of Human Brain of the Russian Academy of Science, St. Petersburg, Russia. | lld:pubmed |
pubmed-article:21128591 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:21128591 | lld:chembl |